5,6-Dihydro-5-Azathymidine: In Vitro Antiviral Properties Against Human Herpesviruses

AUTOR(ES)

Renis, Harold E.

RESUMO

5,6-Dihydro-5-azathymidine (DHAdT), a novel water-soluble nucleoside antibiotic, inhibits herpes simplex virus type 1 (HSV-1) in appropriately infected cell cultures to a greater extent than herpes simplex virus type 2 (HSV-2). Vaccinia virus was less susceptible than HSV-2, and pseudorabies virus yields were not reduced at the concentrations studied. Plaque formation by varicella-zoster virus was suppressed by DHAdT. DHAdT was slightly toxic to cells at concentrations that were inhibitory for HSV-1 and varicella-zoster virus. Thymidine and deoxyuridine completely reversed the anti-HSV-1 activity of DHAdT, whereas deoxycytidine was partially effective. Compared with other nucleoside analogs with activity for HSV-1, DHAdT was less active than 5-iodo-2′-deoxyuridine or 1-β-d-arabinofuranosylcytosine and nearly equipotent with 9-β-d-arabinofuranosyladenine.

Documentos Relacionados

• Activities of 5,6-Dihydro-5-Azathymidine Against Herpes Simplex Virus Infections in Mice
• Efficacy of 5,6-Dihydro-5-Azathymidine Against Cutaneous Herpes Simplex Virus in Hairless Mice
• The effects of 5R-5,6-dihydro-5-hydroxythymidine on duplex DNA stability and structure.
• In vitro activation of human herpesviruses 6 and 7 from latency.
• Antifungal properties in a novel series of triazino[5,6-b]indoles.